publication date: Jul. 30, 2015
20150730 - Jul. 30, 2015
ISSUE 30 – JULY 31, 2015PDF

Pharma Industry Critics

Seek Grassroots Support

 

Many people are studying the rising prices of cancer drugs. A growing group of oncologists want to do something different: they want to give them a downward push.

Last week, a group of 118 oncologists signed an editorial published in the Mayo Clinic Proceedings in which they laid out seven specific actions that they argue would moderate drug prices.

 

Conversation with The Cancer Letter

The War on Cancer (Drug Prices): Political Education of Hagop Kantarjian

Here is what Hagop Kantarjian has learned over the past two years of his campaign to lower the prices of cancer drugs:

People would rather avoid disputing you head-on.

Instead, they seek to draw you into a process. And as this process drags on, things remain as they are.

Kantarjian, chair of the Department of Leukemia at MD Anderson Cancer Center, is too savvy and too impatient to get sucked into chasing elusive solutions.

Baylor Earns Comprehensive Designation;

Tisch Institute Becomes NCI Cancer Center

The Dan L. Duncan Cancer Center at Baylor College of Medicine and the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai received NCI designations this week.

The Duncan Cancer Center—which was named an NCI-designated cancer center in 2007—was awarded the Comprehensive Cancer Center designation, which includes a $14.56 million, five-year grant. 

Guest Editorial

Kids v Cancer: Laws Need to Catch up to the Science

By Nancy Goodman

Kids with cancer are the last, not the first, to get on trials of promising new drugs. And, when drug companies abandon their unapproved cancer drugs, as they do 95 percent of the time for all sorts of reasons, the chance to study those drugs for kids with cancer goes away forever.

Drugs and Targets

Lenvima Receives FDA Breakthrough Designation

In Brief

  • Thomas Lynch Jr. to step down as director of Yale Cancer Center

  • Peter Schulam to serve as interim center director
  • Karen Reckamp named medical director for clinical research at City of Hope

  • Timothy Lash named leader of cancer prevention program at Winship Institute
  • Ontario Institute for Cancer Research and Centre for Drug Research and Development announces call for pre-proposals for early-stage research

Copyright (c) 2020 The Cancer Letter Inc.